规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | m-3M3FBS acts as a potent activator of phospholipase C (PLC), enhancing superoxide production in human neutrophils, increasing intracellular calcium levels, and promoting inositol phosphate generation across various cell lines, leading to apoptosis in monocytic leukemia cells[1].[2].[3]. |
体外研究 | m-3M3FBS triggers the production of inositol phosphates in U937 cells within a concentration range of 5-50 μM[1]. At a 50 μM concentration over 24 hours, m-3M3FBS hampers the proliferation of leukemia cell lines U937 and THP-1 without affecting primary monocytes[3]. Furthermore, under the same conditions, it provokes apoptosis in U937 cells[3]. |
Concentration | Treated Time | Description | References | |
mouse peritoneal macrophages | 10 mM | 30 minutes | inhibited TAK1 phosphorylation and activation of the MAPKs and NF-κB pathways | Nat Commun. 2019 Feb 14;10(1):746 |
HCT 116 cells | 25 μM | Induced intracellular Ca2+ release, leading to mitochondrial inner membrane permeabilization (MIMP) and cell death | Cell Death Differ. 2022 Jul;29(7):1318-1334 | |
HeLa cells | 25 μM | approx. 200–400 s | Induced intracellular Ca2+ release, leading to mitochondrial inner membrane permeabilization (MIMP) and cell death | Cell Death Differ. 2022 Jul;29(7):1318-1334 |
rat hippocampal CA1 pyramidal cells | 30 μM | 60 seconds | restore PLCβ-dependent S-eCB mobilization disrupted by AβO | Alzheimers Res Ther. 2021 Oct 8;13(1):165 |
CHO cells (Chinese hamster ovary cells) | 25 μM | m-3M3FBS caused a slowly developing Ca2+ elevation, though of lower magnitude than in SH-SY5Y cells. No inositol phosphate elevation was observed after 20 minutes of stimulation. | Br J Pharmacol. 2004 Sep;143(1):3-7 | |
SH-SY5Y human neuroblastoma cells | 25 μM | 4-6 minutes | m-3M3FBS caused a slowly developing Ca2+ elevation, indicating Ca2+ release from intracellular stores such as endoplasmic reticulum and mitochondria. No PLC activation was detected within the time frame of Ca2+ elevation (up to 7 minutes). | Br J Pharmacol. 2004 Sep;143(1):3-7 |
mouse ventricular myocytes | 25 μM | m-3M3FBS (a putative PLC activator) suppressed the activation of VRAC current, and this effect was reversed by intracellular excess PIP2 | Br J Pharmacol. 2010 Sep;161(1):193-206 | |
Aplysia bag cell neurons | 25 μM | 20 min | Activation of PLC, mimicking DAG release, induces inward current | J Physiol. 2016 Oct 1;594(19):5573-92 |
WEHI-231 cells | 50 μM | Activated PLC, thereby activating LK bg channels | J Physiol. 2007 Aug 1;582(Pt 3):977-90 | |
platelets | 100, 200, 400 μM | m-3M3FBS, as a direct PLC activator, dose-dependently activated platelet PLCγ2 and induced platelet aggregation. Fc pretreatment partially restored m-3M3FBS-induced platelet aggregation. | Front Pharmacol. 2018 Nov 6;9:1293 | |
T-REx-TRPM3 cells | 5 μM | 3 hours preincubation, 24 hours stimulation | Test the effect of m-3M3FBS on TRPM3 signaling, results showed nearly 98% inhibition of TRPM3 signaling | Int J Mol Sci. 2022 Aug 24;23(17):9590 |
HEK293-M8 cells | 5 μM | 3 hours preincubation, 24 hours stimulation | Test the effect of m-3M3FBS on TRPM8 signaling, results showed nearly 90% inhibition of TRPM8 signaling | Int J Mol Sci. 2022 Aug 24;23(17):9590 |
HEK293 cells | 1 μM | 24 hours | Test the effect of m-3M3FBS on AP-1 activity, results showed 1 μM concentration marginally activated AP-1 activity | Int J Mol Sci. 2022 Aug 24;23(17):9590 |
Administration | Dosage | Frequency | Description | References | ||
Mice | Plcb2 knockout mice | Intraperitoneal injection | 5 mg/kg | Three times (1 day before, 2 days after, and 5 days after infection) | Alleviated CVA16 infection-induced histopathology and prolonged survival | Nat Commun. 2019 Feb 14;10(1):746 |
5XFAD mice | Alzheimer's disease model | Direct hippocampal injection | 50 μM | Single injection, 3-day recovery | Restore hippocampus-dependent contextual fear memory | Alzheimers Res Ther. 2021 Oct 8;13(1):165 |
Least shrew (Cryptotis parva) | Model of vomiting | Intraperitoneal (i.p.) | 50 mg/kg | Single dose, observed for 2 hours | To investigate the emetic potential of m-3M3FBS in the least shrew model of vomiting. It was found that a 50 mg/kg dose induced vomiting in ~90% of tested shrews, accompanied by significant increases in c-Fos expression and ERK1/2 phosphorylation in the brainstem dorsal vagal complex. | Front Pharmacol. 2021 Sep 10;12:736842 |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.91mL 0.58mL 0.29mL |
14.56mL 2.91mL 1.46mL |
29.12mL 5.82mL 2.91mL |
CAS号 | 200933-14-8 |
分子式 | C16H16F3NO2S |
分子量 | 343.36 |
SMILES Code | O=S(C1=C(C)C=C(C)C=C1C)(NC2=CC=CC(C(F)(F)F)=C2)=O |
MDL No. | MFCD00095824 |
别名 | |
运输 | 蓝冰 |
InChI Key | ZIIUUSVHCHPIQD-UHFFFAOYSA-N |
Pubchem ID | 761523 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
溶解方案 |
DMSO: 105 mg/mL(305.8 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|